RJA
GILD icon

Robshaw & Julian Associates’s Gilead Sciences GILD Stock Holding History

Robshaw & Julian Associates’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$3.08M Sell
43,460
-50
-0.1% -$3.33K 2.2% 25
2017
Q1 		$2.96M Buy
43,510
+8,000
+23% +$563K 2.13% 25
2016
Q4 		$2.54M Buy
35,510
+1,925
+6% +$143K 1.88% 28
2016
Q3 		$2.66M Buy
33,585
+2,200
+7% +$179K 1.97% 27
2016
Q2 		$2.62M Buy
31,385
+670
+2% +$59.5K 2% 26
2016
Q1 		$2.82M Buy
30,715
+300
+1% +$27.1K 2.13% 25
2015
Q4 		$3.08M Buy
30,415
+700
+2% +$72.8K 2.38% 23
2015
Q3 		$2.91M Buy
29,715
+900
+3% +$100K 2.46% 23
2015
Q2 		$3.37M Buy
28,815
+725
+3% +$79.2K 2.59% 23
2015
Q1 		$2.77M Buy
28,090
+1,005
+4% +$102K 2.08% 24
2014
Q4 		$2.55M Buy
27,085
+2,800
+12% +$290K 2.01% 23
2014
Q3 		$2.58M Buy
24,285
+780
+3% +$76.4K 2.04% 22
2014
Q2 		$3.01M Buy
23,505
+4,625
+24% +$360K 2.31% 23
2014
Q1 		$1.34M Buy
+18,880
New +$1.48M 1.03% 33

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Robshaw & Julian Associates's GILD Position: Q2 2017 in Review

Robshaw & Julian Associates reduced its Gilead Sciences (GILD) stake by 0.11% in Q2 2017, selling an estimated $3.33K and leaving 43,460 shares worth $3.08M. The position accounts for 2.2% of the portfolio, ranked #25.

Robshaw & Julian Associates first reported a position in GILD in Q1 2014 and has held it in 14 quarters since. The position peaked at $3.37M in Q2 2015. 1,519 funds tracked by Wall St. Rank hold GILD as of Q2 2017.

  • Robshaw & Julian Associates held 43,460 shares of Gilead Sciences worth $3.08M as of Q2 2017.
  • Robshaw & Julian Associates sold 50 Gilead Sciences shares in Q2 2017, an estimated $3.33K.
  • Gilead Sciences made up 2.2% of Robshaw & Julian Associates's portfolio in Q2 2017, its #25 holding.
  • Robshaw & Julian Associates first reported a position in Gilead Sciences in Q1 2014 and has held it in 14 quarters since.
  • Robshaw & Julian Associates's Gilead Sciences position peaked at $3.37M in Q2 2015.
  • 1,519 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2017.

Based on Robshaw & Julian Associates's 13F filing for Q2 2017, filed 3 Aug 2017.